# Nimbus Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nimbus-therapeutics

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.nimbustx.com
- Total disclosed funding: $69M
- Latest round: Series B (Mar 18, 2015)
- Investors on record: 5

## About

Founded in 2009 and based in Massachusetts, US, Nimbus Discovery, Inc. operates as a biotechnology company that develops pharmaceutical solutions by utilizing computational chemistry. Bruce Booth and Ramy Farid co-founded the company, and Jeb Keiper is the current CEO. In July 2021, Nimbus Discovery, Inc. raised USD 105 million in venture funding from BVF Partners L.P., RA Capital Management, Atlas Venture, Access Biotechnology, Commodore Capital, Logos Capital, and Surveyor Capital.
 
The company offers a computational technology-driven paradigm intended to design challenging target medicines and transform drug development for novel diseases such as metabolic diseases, cancer, and immune-inflammatory disorders. The company also designs novel small molecule candidates, enabling physicians to use such medicine to treat various metabolic diseases.
 
Nimbus Discovery, Inc. will use the July 2021 funding to support a human study of the company’s HPK1 inhibitor candidate in cancer patients with solid tumors, which will begin later this year, and will accelerate preclinical programs against multiple targets in oncology and immunology. The company expects to initiate IND-enabling studies on two novel agents in 2022.

## Funding rounds

- Series B, Mar 18, 2015, $43M — Atlas Venture, Lilly Ventures, SR One, Pfizer Venture Investments, Lightstone Ventures
- Series A, Jun 28, 2011, $24M — Atlas Venture, Lilly Ventures, SR One
- Seed, Mar 10, 2011, $1.5M — Atlas Venture

## Investors

- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Seed, Series A, Series B
- Lilly Ventures (https://capitalatlas.ai/funds/lilly-ventures) — Series A, Series B
- SR One (https://capitalatlas.ai/funds/sr-one) — Series A, Series B
- Pfizer Venture Investments (https://capitalatlas.ai/funds/pfizer-venture-investments) — Series B
- Lightstone Ventures (https://capitalatlas.ai/funds/lightstone-ventures) — Series B